An mRNA platform to create isolated, monospecific Th1 responses.

Kathleen S Krauss1,2, Stephen Carro1,3, Michael J Hogan4

  • 1Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.

Summary

Researchers developed a novel mRNA vector for selective immunization, generating a robust, monospecific helper T-cell (CD4 T cell) response. This method effectively elicits CD4 T cells that influence infection outcomes in mouse models.